BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  LAVA Therapeutics to Participate at the UBS Global Healthcare Conference

  LAVA Therapeutics N.V. announced that Stephen Hurly, president and chief executive officer of LAVA Therapeutics, will participate in a fireside chat at the UBS Global Healthcare Conference 2022 being held in New York, NY.

  May 5, 2022

   · 

  1 min read
• Business

  AVEO Oncology Reports First Quarter 2022 Financial Results

  AVEO Oncology today reported financial results for the first quarter ended March 31, 2022.

  May 5, 2022

   · 

  19 min read
• Lone Star Bio

  Aravive to Host Key Opinion Leader Symposium on May 11, 2022

  Aravive, Inc. today announced that it will host a Key Opinion Leader (KOL) Symposium on the GAS6-AXL signaling pathway and the Company’s lead drug candidate, batiraxcept.

  May 5, 2022

   · 

  2 min read
• Business

  BioCryst Reports First Quarter 2022 Financial Results and Upcoming Key Milestones

  BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported financial results for the first quarter ended March 31, 2022, and provided a corporate update.

  May 5, 2022

   · 

  14 min read
• Business

  Autolus Therapeutics Reports First Quarter 2022 Financial Results and Operational Progress- Conference call to be held on May 5, 2022 at 8:30 am ET/1:30 pm BST -

  Autolus Therapeutics plc today announced its operational and financial results for the quarter ended March 31, 2022.

  May 5, 2022

   · 

  19 min read
• Business

  Sotera Health Reports First-Quarter 2022 Results

  Sotera Health Company, a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced financial results for the three months ended March 31, 2022.

  May 5, 2022

   · 

  25 min read
• Genetown

  Lyra Therapeutics to Present at Upcoming Investor Conferences

  Lyra Therapeutics, Inc. today announced that Maria Palasis, Ph.D., Lyra’s President and Chief Executive Officer, will present at two upcoming investor conferences.

  May 5, 2022

   · 

  5 min read
• Business

  Akumin to Host First Quarter 2022 Financial Results Call on May 11, 2022

  Akumin Inc. will host a conference call at 8:30 a.m. Eastern Time , May 11, 2022 , to discuss its first quarter 2022 financial results.

  May 5, 2022

   · 

  3 min read
• Business

  Aldeyra Therapeutics Reports First-Quarter 2022 Financial Results and Recent Corporate Highlights

  Aldeyra Therapeutics, Inc. today reported recent corporate highlights and financial results for the quarter ended March 31, 2022.

  May 5, 2022

   · 

  13 min read
• Business

  Axcella Reports First Quarter 2022 Financial Results and Provides Business Update

  Axcella Therapeutics, a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator compositions, announced financial results for the first quarter ended March 31, 2022 and provided a business update.

  May 5, 2022

   · 

  7 min read